An elevated fibrinogen/CRP ratio predicts a remarkable survival advantage in patients with metastatic pancreatic cancer
- T Winder (Author)
- Posch, F. (Author)
- E Asamer (Author)
- Stotz, M. (Author)
- A Siebenhuner (Author)
- Konstantin Schlick (Author)
- T Magnes (Author)
- P Samaras (Author)
- Szkandera, J. (Author)
- PA Clavien (Author)
- D Neureiter (Author)
- R Greil (Author)
- BC Pestalozzi (Author)
- Stöger, H. (Author)
- Armin Gerger (Author)
- A Egle (Author)
- Martin Pichler (Author)
Activity: Talk, presentation or poster › Poster